NL-OMON38010已完成不适用
Bèta-TCP (bèta-tricalcium phosphate) as a bone substitute in patients undergoing repair of the alveolar cleft in CLP(Cleft Lip Palate) patients. - Grafting CLP patients with a bone substitute: Bèta-TCP
niversitair Medisch Centrum Utrecht0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2 至 11（—）
入选标准
- •Children with cleft of lip, alveolus and palate with radiological proof of half-developmental stage of the root of the upper canine or a viable lateral incisor
排除标准
- •No cleft of lip, alveolus and palate.
研究者
相似试验
已完成
不适用
The use of β-TCP (bèta-tricalcium phosphate) as a filler of the autologous symphyseal bone graft harvest site in patients undergoing grafting of alveolar clefts in CLAP(Cleft Lip Alveolus Palate) patientscheilognathopalatoschisisalveolus and palate/HarelipCleft of lip1002766410019190NL-OMON30182Academisch Medisch Centrum20
尚未招募
1 期
A clinical trial to study effect of Allogenic human pulp derived mesenchymal stem cells in patients with intrabony defectsCTRI/2018/02/011734Harini Mitta
招募中
不适用
se of block of beta tricalcium phosphate to enhance the bone disponibility for the implants placementRBR-6hbztwFaculdade de Odontologia de Araraquara-Unesp
已完成
不适用
sing of beta-tricalcium phosphate-based bone grafting material before and during the primary implant placementmissing toothJPRN-UMIN000042854Iwate Medical University10
撤回
不适用
The use of Progentix TCP (beta-tricalciumphosphate) as a bone substitute in defects originated from curettage of benign bone tumorsNL-OMON31641Medisch Spectrum Twente10